🔗 Share this article

A shadow economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Experimental Drug Gaining Popularity Via Social Media

Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are encouraged to contact these accounts privately for source information, while also obtaining promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where groups with thousands of participants share comparison images, administration instructions and claims of next-day British shipping. Sellers market the substance there before directing customers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Professionals Voice Concerns

Nevertheless, doctors and chemists have cautions that the sale of what remains an unapproved medication in the UK is a cause for concern and could lead to users injecting substances of unknown origin.

Several professionals stated the popularity for retatrutide could be linked to the increasing price of licensed weight loss products such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for human use under the British medical regulations.

Several influencers attempt to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate pharmaceutical, marketing, and customer laws, risking penalties, legal action or prison.

Platform Response and Material Removal

According to the social media company, the platform has removed violative material and banned related keywords and query recommendations. The company stated it was committed to keeping the platform secure and investing in strengthening compliance measures.

Online Trading Activities

Investigations also discovered communities with up to 9,000 participants marketing retatrutide using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately displays groups with thousands of members, populated with photos of slimming results, positive testimonials and step-by-step guides for mixing or administering at home.

Within minutes of entering one group, a vendor posted WhatsApp details, where the majority of purchases take place. The vendor provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None asked about weight, health issues or previous experience.

Product Information and Pricing

Within these communities, messages show dark colored packages with Royal Mail stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20 milligrams. When questioned how long a pen should last, vendors give contradictory responses varying between a several days to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for Telegram stated it regularly moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering materials they cannot confirm. Even if the science behind this drug is sound, these online products may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.

Her staff has previously seen individuals harmed by self-injection from unverified suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may expose users to potentially serious medical dangers”.